Lysolipids
lipidLysolipids generated from lipoprotein remodeling act as endothelial and immune-cell activators, driving plaque inflammation.
Pathway placement
Cascade stepPlaque inflammation
Confidencehigh
RationaleBioactive lipid mediators; promote endothelial activation, monocyte recruitment and plaque inflammation.
Also acts inLipid entry/oxidation
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma (EDTA to limit oxidation)
Collection tube
K2/K3-EDTA (lavender-top) · Serum separator (gold/red-top, SST)
Method / principle
LC-MS/MS lipidomics (targeted or shotgun)
Reagent / substrate
Deuterated lipid-class internal standards; MS/MS transitions
Platform
LC-MS/MS
Turnaround · availability
Research · Research-only
Literature evidence(1)
- Bioactive lipids in plasma and atherogenic apoB-containing lipoproteins: Effects of statins and PCSK9 inhibitors and relevance to residual cardiovascular risk.Pharmacology & therapeutics · 2026 · PMID 42162924 · doi